01 July 1999
Familial occurrence of hypertrophic cardiomyopathy
Wojciech Ozimek, Maria Wróblewska-KałużewskaMed Sci Monit 1999; 5(4): CR669-674 :: ID: 503475
Abstract
Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder characterized by asymmetric left ventricular hypertrophy with myocyte and myofibrillar disarray. The wide diversity in cardiac morphology, pathophysiologic features and clinical manifestations is evident even within the same family. The aim of this study was to screen a group of patients for the incidence of familial hypertrophic cardiomyopathy (FHC). The study group comprised 65 subjects - members of 12 unrelated families. Overall, HCM was diagnosed in 24 out of 65 patients, mostly male - 20 cases. There were two cases of cardiomyopathy in women. FHC was confirmed in 7 out of the 12 screened families. Most often hypertrophy involved substantial portions of both the ventricular septum and anterolateral left ventricular free wall and qualified as type III, according to Marons' classification. During a 3 year follow-up period we observed no characteristics of progressive left ventricular hypertrophy nor left ventricular failure amongst 16 subjects treated with verapamil for an average period of 2 years and those without medication. The pattern of left venricular hypertrophy distribution was similar between first degree relatives, but the degree of hypertrophy varied significantly. The authors did not observe correlations between the pattern of distribution and degree of left ventricular hypertrophy, ecg disturbances and clinical manifestations.
Keywords: hypertrophic cardiomyopathy, Epidemiology, familial occurrence
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952